|
2020-12-11 |
2020-12-09 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
2.793
-49.7%
79,69
222.574 USD
|
2.793
-49.7%
|
79,69
|
222.574 USD
|
|
|
2020-11-17 |
2020-11-16 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
7.603
-57.5%
86,57
658.192 USD
|
7.603
-57.5%
|
86,57
|
658.192 USD
|
|
|
2020-11-17 |
2020-11-13 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
13.282
-70.3%
83,82
1.113.318 USD
|
13.282
-70.3%
|
83,82
|
1.113.318 USD
|
|
|
2020-11-12 |
2020-11-10 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
6.000
-51.6%
81,57
489.420 USD
|
6.000
-51.6%
|
81,57
|
489.420 USD
|
|
|
2020-11-06 |
2020-11-05 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
3.589
-39.0%
79,87
286.653 USD
|
3.589
-39.0%
|
79,87
|
286.653 USD
|
|
|
2020-11-06 |
2020-11-04 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
3.434
-37.9%
79,89
274.351 USD
|
3.434
-37.9%
|
79,89
|
274.351 USD
|
|
|
2020-11-06 |
2020-11-04 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
139
-0.6%
80,00
11.120 USD
|
139
-0.6%
|
80,00
|
11.120 USD
|
|
|
2020-11-06 |
2020-11-04 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
2.481
-9.7%
80,00
198.481 USD
|
2.481
-9.7%
|
80,00
|
198.481 USD
|
|
|
2020-10-20 |
2020-10-16 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
183
-3.2%
79,87
14.616 USD
|
183
-3.2%
|
79,87
|
14.616 USD
|
|
|
2020-10-07 |
2020-10-07 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
1.500
-6.1%
78,50
117.753 USD
|
1.500
-6.1%
|
78,50
|
117.753 USD
|
|
|
2020-10-07 |
2020-10-06 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
4.778
-17.2%
78,50
375.094 USD
|
4.778
-17.2%
|
78,50
|
375.094 USD
|
|
|
2020-10-07 |
2020-10-05 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
14.637
-38.9%
78,51
1.149.110 USD
|
14.637
-38.9%
|
78,51
|
1.149.110 USD
|
|
|
2020-06-10 |
2020-06-08 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
1.415
-5.8%
78,50
111.078 USD
|
1.415
-5.8%
|
78,50
|
111.078 USD
|
|
|
2020-05-19 |
2020-05-15 |
K
Kauf
|
MURRAY JAMES E
President and COO
Führungsperson
|
4.500
+inf%
67,63
304.317 USD
|
4.500
+inf%
|
67,63
|
304.317 USD
|
|
|
2020-01-03 |
2020-01-02 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
200
-1.0%
78,53
15.706 USD
|
200
-1.0%
|
78,53
|
15.706 USD
|
|
|
2019-12-31 |
2019-12-30 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
104
-0.5%
78,50
8.164 USD
|
104
-0.5%
|
78,50
|
8.164 USD
|
|
|
2019-12-30 |
2019-12-27 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
606
-2.9%
78,54
47.597 USD
|
606
-2.9%
|
78,54
|
47.597 USD
|
|
|
2019-12-27 |
2019-12-26 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
1.923
-8.7%
78,52
150.987 USD
|
1.923
-8.7%
|
78,52
|
150.987 USD
|
|
|
2019-12-26 |
2019-12-24 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
6.114
-23.3%
78,54
480.166 USD
|
6.114
-23.3%
|
78,54
|
480.166 USD
|
|
|
2019-12-17 |
2019-12-16 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
5.735
-22.1%
78,62
450.886 USD
|
5.735
-22.1%
|
78,62
|
450.886 USD
|
|
|
2019-12-11 |
2019-12-09 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
16.766
-85.7%
78,72
1.319.742 USD
|
16.766
-85.7%
|
78,72
|
1.319.742 USD
|
|
|
2018-07-03 |
2018-07-02 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-30.5%
95,86
1.282.061 USD
|
13.375
-30.5%
|
95,86
|
1.282.061 USD
|
|
|
2018-06-04 |
2018-06-01 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-30.5%
92,21
1.233.326 USD
|
13.375
-30.5%
|
92,21
|
1.233.326 USD
|
|
|
2018-05-02 |
2018-05-01 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-23.2%
86,02
1.150.576 USD
|
13.375
-23.2%
|
86,02
|
1.150.576 USD
|
|
|
2018-04-04 |
2018-04-02 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
Führungsperson
|
1.666
-100.0%
106,20
176.929 USD
|
1.666
-100.0%
|
106,20
|
176.929 USD
|
|
|
2018-04-04 |
2018-04-02 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-23.2%
103,52
1.384.583 USD
|
13.375
-23.2%
|
103,52
|
1.384.583 USD
|
|
|
2018-03-06 |
2018-03-05 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
15.428
-100.0%
99,04
1.527.968 USD
|
15.428
-100.0%
|
99,04
|
1.527.968 USD
|
|
|
2018-03-06 |
2018-03-05 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
22.875
-63.0%
99,05
2.265.698 USD
|
22.875
-63.0%
|
99,05
|
2.265.698 USD
|
|
|
2018-03-02 |
2018-03-01 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-31.2%
101,20
1.353.497 USD
|
13.375
-31.2%
|
101,20
|
1.353.497 USD
|
|
|
2018-02-02 |
2018-02-01 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.375
-31.2%
99,20
1.326.765 USD
|
13.375
-31.2%
|
99,20
|
1.326.765 USD
|
|
|
2018-01-04 |
2018-01-03 |
V
Verkauf
|
Rubin Jonathan N
Chief Financial Officer
Führungsperson
|
30.086
-53.2%
96,16
2.893.028 USD
|
30.086
-53.2%
|
96,16
|
2.893.028 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Verkauf
|
SMITH BARRY M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
13.367
-31.2%
95,94
1.282.429 USD
|
13.367
-31.2%
|
95,94
|
1.282.429 USD
|
|
|
2018-01-03 |
2018-01-02 |
V
Verkauf
|
Rubin Jonathan N
Chief Financial Officer
Führungsperson
|
17.443
-39.7%
96,07
1.675.782 USD
|
17.443
-39.7%
|
96,07
|
1.675.782 USD
|
|
|
2017-12-06 |
2017-12-04 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2.180
-100.0%
92,00
200.560 USD
|
2.180
-100.0%
|
92,00
|
200.560 USD
|
|
|
2017-12-05 |
2017-12-04 |
V
Verkauf
|
Lewis Clapper Caskie
Chief Human Resources Officer
|
59.313
-76.3%
93,99
5.574.586 USD
|
59.313
-76.3%
|
93,99
|
5.574.586 USD
|
|
|
2017-12-04 |
2017-12-01 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
8.275
-38.1%
89,08
737.137 USD
|
8.275
-38.1%
|
89,08
|
737.137 USD
|
|
|
2017-11-02 |
2017-11-01 |
GV
Geplanter Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
9.369
-41.0%
89,20
835.751 USD
|
9.369
-41.0%
|
89,20
|
835.751 USD
|
|
|
2017-11-02 |
2017-11-01 |
GV
Geplanter Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1.154
-100.0%
92,00
106.168 USD
|
1.154
-100.0%
|
92,00
|
106.168 USD
|
|
|
2017-10-05 |
2017-10-04 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
2.475
-15.5%
88,10
218.048 USD
|
2.475
-15.5%
|
88,10
|
218.048 USD
|
|
|
2017-10-05 |
2017-10-04 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
5.000
-23.9%
88,00
440.000 USD
|
5.000
-23.9%
|
88,00
|
440.000 USD
|
|
|
2017-10-05 |
2017-10-03 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
5.000
-27.1%
88,00
440.000 USD
|
5.000
-27.1%
|
88,00
|
440.000 USD
|
|
|
2017-10-04 |
2017-10-03 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
30.021
-68.3%
87,31
2.621.242 USD
|
30.021
-68.3%
|
87,31
|
2.621.242 USD
|
|
|
2017-10-03 |
2017-10-02 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
19.007
-57.7%
86,22
1.638.689 USD
|
19.007
-57.7%
|
86,22
|
1.638.689 USD
|
|
|
2017-10-03 |
2017-09-29 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
18.511
-57.1%
86,18
1.595.317 USD
|
18.511
-57.1%
|
86,18
|
1.595.317 USD
|
|
|
2017-09-29 |
2017-09-28 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
4.848
-100.0%
85,76
415.782 USD
|
4.848
-100.0%
|
85,76
|
415.782 USD
|
|
|
2017-09-29 |
2017-09-28 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
25.316
-64.5%
85,85
2.173.452 USD
|
25.316
-64.5%
|
85,85
|
2.173.452 USD
|
|
|
2017-09-29 |
2017-09-27 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
1.419
-9.2%
86,06
122.125 USD
|
1.419
-9.2%
|
86,06
|
122.125 USD
|
|
|
2017-09-29 |
2017-09-27 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
|
18.502
-54.7%
85,24
1.577.131 USD
|
18.502
-54.7%
|
85,24
|
1.577.131 USD
|
|
|
2017-09-28 |
2017-09-27 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
35.658
-72.6%
85,17
3.036.928 USD
|
35.658
-72.6%
|
85,17
|
3.036.928 USD
|
|
|
2017-09-28 |
2017-09-27 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
600
-100.0%
86,06
51.635 USD
|
600
-100.0%
|
86,06
|
51.635 USD
|
|
|
2017-09-28 |
2017-09-27 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
18.526
-96.9%
85,31
1.580.373 USD
|
18.526
-96.9%
|
85,31
|
1.580.373 USD
|
|
|
2017-09-18 |
2017-09-15 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2.402
-15.1%
83,00
199.366 USD
|
2.402
-15.1%
|
83,00
|
199.366 USD
|
|
|
2017-09-18 |
2017-09-15 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
2.961
-100.0%
84,00
248.724 USD
|
2.961
-100.0%
|
84,00
|
248.724 USD
|
|
|
2017-09-18 |
2017-09-14 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
18.063
-57.3%
83,05
1.500.163 USD
|
18.063
-57.3%
|
83,05
|
1.500.163 USD
|
|
|
2017-09-14 |
2017-09-13 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
585
-100.0%
83,00
48.555 USD
|
585
-100.0%
|
83,00
|
48.555 USD
|
|
|
2017-09-14 |
2017-09-13 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
14.096
-51.2%
83,06
1.170.883 USD
|
14.096
-51.2%
|
83,06
|
1.170.883 USD
|
|
|
2017-09-14 |
2017-09-12 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
19
-100.0%
83,00
1.577 USD
|
19
-100.0%
|
83,00
|
1.577 USD
|
|
|
2017-09-12 |
2017-09-11 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
670
-100.0%
83,00
55.610 USD
|
670
-100.0%
|
83,00
|
55.610 USD
|
|
|
2017-09-12 |
2017-09-11 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
|
2.400
-15.1%
83,00
199.200 USD
|
2.400
-15.1%
|
83,00
|
199.200 USD
|
|
|
2017-09-11 |
2017-09-08 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
6.267
-100.0%
81,53
510.918 USD
|
6.267
-100.0%
|
81,53
|
510.918 USD
|
|
|
2017-09-08 |
2017-09-07 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1.033
-100.0%
81,19
83.870 USD
|
1.033
-100.0%
|
81,19
|
83.870 USD
|
|
|
2017-09-08 |
2017-09-05 |
V
Verkauf
|
Kamal Mostafa
CEO, Magellan Rx Management
|
1.157
-100.0%
80,96
93.669 USD
|
1.157
-100.0%
|
80,96
|
93.669 USD
|
|
|
2017-07-26 |
2017-07-25 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
4.559
-25.3%
80,68
367.820 USD
|
4.559
-25.3%
|
80,68
|
367.820 USD
|
|
|
2017-07-25 |
2017-07-24 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
32.398
-70.7%
80,12
2.595.582 USD
|
32.398
-70.7%
|
80,12
|
2.595.582 USD
|
|
|
2017-07-25 |
2017-07-21 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
1.176
-8.0%
80,02
94.102 USD
|
1.176
-8.0%
|
80,02
|
94.102 USD
|
|
|
2017-07-21 |
2017-07-20 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
16.073
-54.4%
80,06
1.286.751 USD
|
16.073
-54.4%
|
80,06
|
1.286.751 USD
|
|
|
2017-07-21 |
2017-07-20 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
1.109
-7.4%
80,01
88.728 USD
|
1.109
-7.4%
|
80,01
|
88.728 USD
|
|
|
2017-07-18 |
2017-07-17 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
600
-4.1%
80,10
48.060 USD
|
600
-4.1%
|
80,10
|
48.060 USD
|
|
|
2017-07-18 |
2017-07-14 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
27.914
-66.7%
80,07
2.234.940 USD
|
27.914
-66.7%
|
80,07
|
2.234.940 USD
|
|
|
2017-07-17 |
2017-07-14 |
V
Verkauf
|
GREGOIRE DANIEL N
General Counsel and Secretary
Führungsperson
|
14.114
-51.2%
80,11
1.130.685 USD
|
14.114
-51.2%
|
80,11
|
1.130.685 USD
|
|
|
2017-02-27 |
2017-02-24 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
100
-0.9%
82,10
8.210 USD
|
100
-0.9%
|
82,10
|
8.210 USD
|
|
|
2017-02-27 |
2017-02-24 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
100
-0.9%
81,05
8.105 USD
|
100
-0.9%
|
81,05
|
8.105 USD
|
|
|
2017-02-27 |
2017-02-24 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
100
-0.9%
80,00
8.000 USD
|
100
-0.9%
|
80,00
|
8.000 USD
|
|
|
2017-02-27 |
2017-02-23 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
300
-2.5%
81,12
24.335 USD
|
300
-2.5%
|
81,12
|
24.335 USD
|
|
|
2017-02-27 |
2017-02-23 |
V
Verkauf
|
WEST JEFFREY N
SVP & Controller
Führungsperson
|
12.912
-51.9%
80,28
1.036.516 USD
|
12.912
-51.9%
|
80,28
|
1.036.516 USD
|
|
